Editorial Team
The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.
Editor-in-Chief
Prof. Zefei Jiang, MD
Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
Editorial Board
Matti Aapro
Cancer Center, Clinique de Genolier, Genolier, Switzerland
Serena Bertozzi
Department of Surgery, Breast Unit, DAME, University Hospital of "Santa Maria della Misericordia", 33100 Udine, Italy
Daniela Bonofiglio
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, via P. Bucci, 87036 Arcavacata di Rende, Italy
George Adrian Calin, MD, PhD
Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Fatima Cardoso
Senior Consultant, Medical Oncology, President ABC Global Alliance, Lisbon, Portugal
Jiayi Chen, MD, PhD
Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Délio Marques Conde, MD, PhD
Department of Gynecology and Obstetrics, School of Medicine, Federal University of Goiás, Goiânia, Brazil
Massimo Cristofanilli, MD, FACP
Weill Cornell Medicine, Division of Hematology-Oncology, New York, NY, 0065, USA
Xiaojiang Cui
Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Giuseppe Curigliano
European Institute of Oncology, IRCCS and Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy
Andrew A. Davis
Department of Medicine, Division of Oncology, Washington University in St. Louis, USA
Andrea Di Blasio, PhD, MSC, BSc
Researcher, Department of Medicine and Aging Sciences, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy
Jimmy T. Efird
VA Cooperative Studies Program Coordinating Center, Boston, MA, USA; Department of Radiation Oncology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
Zhimin Fan, MD
Department of Breast Surgery, The First Hospital of Jilin University, Changchun, China
Gianluca Franceschini, PhD
Professor of General Surgery and Head of Breast Unit at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, Rome, Italy
Cuizhi Geng, MD, PhD
Department of Breast Center, Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Michael Gnant, MD FACS FEBS
Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
Anurag Gupta, MBBS, MS, FRACS
Lyell McEwin and Modbury Hospitals, University of Adelaide, Adelaide, Australia
Chunfang Hao
Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Cancer Hospital Airport Hospital, Tianjin, China
Nadia Harbeck, MD
Dept. of OB&GYN, LMU University Hospital, Munich, Germany
Jian Huang, MD, PhD
Department of Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Marcello Iriti
Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, 20133, Milan, Italy.
Jacek Jassem, MD, PhD
Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk 80-211, Poland
Feng Jin, MD, PhD
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
Tomonori Kawasaki, MD, PhD
Professor, Department of Pathology, Saitama Medical University, Hidaka, Japan
Rainer Johannes Klement
Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Germany
Alan Prem Kumar, PhD
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Caterina A. M. La Porta, PhD
Full professor of General Pathology, Department of Environmental Science and Policy, Center for Complexity and Biosystems, University of Milan, Milan Italy
Christine U. Lee, MD, PhD
Mayo Clinic, Department of Radiology, Division of Breast Imaging and Intervention, Rochester, MN 55905, USA
Jose Pablo Leone, MD
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Lin Z. Li, PhD
Britton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Yueping Liu
Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Yinhua Liu
Breast Disease Center, Peking University First Hospital, Beijing, China
Qiang Liu, MD, PhD
Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Yunjiang Liu, MD, PhD
Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Hebei Medical University, Shijiazhuang, China
Jochen Maurer, PhD
PI, Department of Gynecology and Obstetrics, University Hospital RWTH Aachen, Aachen, Germany
Sherif Monib
Consultant Breast Surgeon, Breast Unit, West Hertfordshire Teaching Hospitals NHS Trust, Hertfordshire, UK
Ángel Montero, MD, PhD
Department of Radiation Oncology, University Hospital HM Sanchinarro, Madrid, Spain
Felix M. Mottaghy, MD
Department of Nuclear Medicine and Comprehensive diagnostic centre Aachen (CDCA), University Hospital RWTH Aachen University, Aachen, Germany; Department of Radiology and Nuclear Medicine, MUMC+, Maastricht, The Netherlands.
Seigo Nakamura, MD, PhD
Director, Institute for Clinical Genetics and Genomics, Showa University; Director, Breast Center of Showa University Hospital; Professor, Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan
Terry L. Ng
Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
Jianyun Nie, MD, PhD
Department of Breast Cancer, Yunnan Cancer Center, Third Affiliated Hospital of Kunming Medical University, Kunming, China
Carlos Eduardo Paiva, MD, PhD
Department of Clinical Oncology, Barretos Cancer Hospital, Barretos, São Paulo, Brazil
Yueyin Pan, MD
Department of Medical Oncology, The First Affiliated Hospital of USTC, Hefei, China
Jai Prakash
Engineered Therapeutics, Department of Advanced Organ Bioengineering and Therapeutics, TechMed Centre, Faculty of Science and Technology, University of Twente, Drienerlolaan 5, 7500AE, Enschede, The Netherlands
Alan Richardson
The School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University, Thornburrow Drive, Stoke-on-Trent ST4 7QB, Staffordshire, UK
Alessandro Rizzo
Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico "Don Tonino Bello", I.R.C.C.S. Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Hope S. Rugo, MD, FASCO
Breast Oncology and Clinical Trials Education, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA
Shigehira Saji, MD, PhD
Department of Medical Oncology, Fukushima Medical University Hospital, Fukushima, Japan
Ara Salibian
Division of Plastic & Reconstructive Surgery, University of California Davis School of Medicine, Sacramento, CA, USA
Alejandro Martin Sanchez, MD
Multidisciplinary Breast Center, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
Eiichi Sasaki, MD, PhD
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Ishith Seth
Department of Plastic Surgery, Peninsula Health, Melbourne, VIC 3199, Australia
Erwei Song, MD
Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Laura M. Spring, MD
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA
Md Abdus Subhan
Division of Nephrology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA
Gang Sun
Department of Breast and Thyroid Surgical Oncology, The Affiliated Cancer Hospital of Xinjiang Medical University, Xinjiang Cancer Center, Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, Urumqi, Xinjiang, China
Tao Sun, MD
Department of Breast Oncology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang, China
Mona P. Tan
MammoCare: Breast Clinic and Surgery in Singapore, Singapore, 228510, Singapore
Masakazu Toi, MD, PhD
Breast Cancer Unit, Kyoto University Hospital, Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
Dario Trapani, MD
Assistant Professor, Medical Oncologist, Department of Oncology and Hematology, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, Milan, Italy
Ioannis A. Voutsadakis
Algoma District Cancer Program, Sault Area Hospital, Sault Ste. Marie, ON P6B 0A8, Canada
Kun Wang
Department of Breast Cancer, Cancer Center, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
Haibo Wang, MD
Department of Breast Disease Center, the Affiliated Hospital of Qingdao University, Qingdao, China
Shu Wang, MD, PhD
Center for Breast, People's Hospital of Peking University, Beijing, China
Shusen Wang, MD, PhD
Department of Medical Oncology, Cancer center of Sun Yat-sen University, Guangzhou, China
Xiaojia Wang, MD, PhD
Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China
Jiong Wu, PhD
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
Jielai Xia, PhD
Department of Health Statistics, College of Military Preventive Medicine, the Fourth Military Medical University, Xi'an, China
Yingying Xu, MD
Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China
Murali M. Yallapu, PhD
Department of Immunology and Microbiology, South Texas Center of Excellence in Cancer Research, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
Toshinari Yamashita, MD, PhD
Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan
Yongmei Yin, MD, PhD
Department of Oncology, The First Affiliated Hospital of Nanjing Medical University. Nanjing, China
Zhigang Yu, MD, PhD
Department of Breast Surgery, the Second Hospital of Shandong University, Jinan, China
Jian Zhang, MD, PhD
Department of Medical Oncology/Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center (FUSCC), Shanghai, China
Qingyuan Zhang, MD, PhD
Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China
Ying Zheng
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China
Managing Editor
Jianbin Li, PhD
Laboratory of Medical Molecular Biology, Department of Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China